Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Brain Drain? Four Agency Staffers Join McClellan At CMS

This article was originally published in The Pink Sheet Daily

Executive Summary

The Centers for Medicare & Medicaid Services administrator is surrounding himself with some of his closest advisors as CMS gears up to implement the Medicare Rx drug benefit. None of the four staffers had line operation functions at FDA.

You may also be interested in...



CMS Medical Technology Advisor Gottlieb Returning To AEI

He will serve as a fellow at the American Enterprise Institute and plans to launch a new publication in conjunction with Forbes on emerging medical technology. Gottlieb was an AEI fellow prior to joining FDA, where he served as medical policy development director before leaving for CMS.

CMS Medical Technology Advisor Gottlieb Returning To AEI

He will serve as a fellow at the American Enterprise Institute and plans to launch a new publication in conjunction with Forbes on emerging medical technology. Gottlieb was an AEI fellow prior to joining FDA, where he served as medical policy development director before leaving for CMS.

FDA External Relations Head Pitts Will Leave Agency June 18

Associate Commissioner for External Relations Peter Pitts will join the public relations firm Manning, Selvage & Lee as VP-health affairs. During his 14-month tenure at FDA, the agency adopted a more aggressive communications approach.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059614

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel